• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

作者信息

Dion Marie, Ankawi Ghada, Chew Ben, Paterson Ryan, Sultan Nabil, Hoddinott Patti, Razvi Hassan

机构信息

Division of Urology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Division of Nephrology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

出版信息

Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E347-E358. doi: 10.5489/cuaj.4218. Epub 2016 Nov 10.

DOI:10.5489/cuaj.4218
PMID:28096919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5234401/
Abstract
摘要

相似文献

1
CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.《加拿大泌尿外科协会肾结石患者评估与药物治疗指南——2016年更新版》
Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E347-E358. doi: 10.5489/cuaj.4218. Epub 2016 Nov 10.
2
2023 UPDATE - Canadian Urological Association guideline: Management of cystic renal lesions Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive Board.2023年更新——加拿大泌尿外科协会指南：囊性肾病变的管理 在最初发布（2017年3月）之前，本指南经过了加拿大泌尿外科协会指南委员会、广大加拿大泌尿外科协会成员以及加拿大泌尿外科协会执行委员会的审查。2023年的更新内容已获加拿大泌尿外科协会指南委员会和加拿大泌尿外科协会执行委员会批准。
Can Urol Assoc J. 2023 Jun;17(6):162-174. doi: 10.5489/cuaj.8389.
3
Metabolic evaluation guidelines in patients with nephrolithiasis: Are they being followed? Results of a national, multi-institutional, quality-assessment study.肾结石患者的代谢评估指南：是否得到遵循？一项全国性、多机构质量评估研究的结果
Can Urol Assoc J. 2018 Oct;12(10):313-318. doi: 10.5489/cuaj.5155. Epub 2018 May 28.
4
Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.尿石症：评估、饮食因素和医学管理：2014 年 SIU-ICUD 国际结石病咨询会议的更新。
World J Urol. 2017 Sep;35(9):1331-1340. doi: 10.1007/s00345-017-2000-1. Epub 2017 Feb 3.
5
Compliance of the recurrent renal stone former with current best practice guidelines.复发性肾结石患者对当前最佳实践指南的依从性。
Can Urol Assoc J. 2018 Mar;12(3):E112-E120. doi: 10.5489/cuaj.4605. Epub 2017 Dec 22.
6
Clinical Practice Guideline: Sudden Hearing Loss (Update).临床实践指南：突发性聋（更新）。
Otolaryngol Head Neck Surg. 2019 Aug;161(1_suppl):S1-S45. doi: 10.1177/0194599819859885.
7
Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary.临床实践指南：突发性聋（更新）执行摘要。
Otolaryngol Head Neck Surg. 2019 Aug;161(2):195-210. doi: 10.1177/0194599819859883.
8
Medical management of kidney stones: AUA guideline.肾结石的医学管理：AUA 指南。
J Urol. 2014 Aug;192(2):316-24. doi: 10.1016/j.juro.2014.05.006. Epub 2014 May 20.
9
Clinical Practice Guideline: Tonsillectomy in Children (Update).临床实践指南：儿童扁桃体切除术（更新）。
Otolaryngol Head Neck Surg. 2019 Feb;160(1_suppl):S1-S42. doi: 10.1177/0194599818801757.
10
Clinical Practice Guideline: Tonsillectomy in Children (Update)-Executive Summary.临床实践指南：儿童扁桃体切除术（更新）-执行摘要。
Otolaryngol Head Neck Surg. 2019 Feb;160(2):187-205. doi: 10.1177/0194599818807917.

引用本文的文献

1
Antioxidant and Anti-Inflammatory Effects of Traditional Medicinal Plants for Urolithiasis: A Scoping Review.用于治疗尿石症的传统药用植物的抗氧化和抗炎作用：一项范围综述
Plants (Basel). 2025 Jul 2;14(13):2032. doi: 10.3390/plants14132032.
2
Brazilian Guidelines on evaluation and clinical management of Nephrolithiasis: Brazilian Society of Nephrology.巴西肾结石评估与临床管理指南：巴西肾脏病学会
J Bras Nefrol. 2025 Apr-Jun;47(2):e20240189. doi: 10.1590/2175-8239-JBN-2024-0189en.
3
Effect of two vitamin D repletion protocols on 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency: a randomized clinical trial.两种维生素 D 补充方案对复发性钙肾结石合并维生素 D 缺乏症患者 24 小时尿钙的影响：一项随机临床试验。
Eur J Med Res. 2023 Jul 22;28(1):246. doi: 10.1186/s40001-023-01226-z.
4
A functional -1562C>T polymorphism, MMP-9 serum levels and nephrolithiasis risk in a southern Chinese population.中国南方人群中功能性-1562C>T多态性、基质金属蛋白酶-9血清水平与肾结石风险
Front Med (Lausanne). 2023 Jun 2;10:1175798. doi: 10.3389/fmed.2023.1175798. eCollection 2023.
5
Fluid intake recommendations in urolithiasis and general advice to patients without metabolic risk factors.尿石症患者的液体摄入建议和无代谢危险因素患者的一般建议。
World J Urol. 2023 May;41(5):1251-1259. doi: 10.1007/s00345-023-04285-3. Epub 2023 Jan 24.
6
On the rocks: can urologists identify stone composition based on endoscopic images alone? A worldwide survey of urologists.仅凭内镜图像，泌尿外科医生能识别结石成分吗？一项针对泌尿外科医生的全球调查。
World J Urol. 2023 Feb;41(2):575-579. doi: 10.1007/s00345-022-04269-9. Epub 2023 Jan 6.
7
International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis.国际尿石症联盟（IAU）尿路结石代谢评估与医学管理指南。
Urolithiasis. 2022 Dec 1;51(1):4. doi: 10.1007/s00240-022-01387-2.
8
Diet and Stone Disease in 2022.2022年的饮食与结石病
J Clin Med. 2022 Aug 13;11(16):4740. doi: 10.3390/jcm11164740.
9
Lanthanum carbonate to control plasma and urinary oxalate level in type 1 primary hyperoxaluria?碳酸镧能否控制1型原发性高草酸尿症患者的血浆和尿草酸水平？
IJU Case Rep. 2021 May 13;4(4):235-238. doi: 10.1002/iju5.12296. eCollection 2021 Jul.
10
Genetic polymorphisms as prognostic factors for recurrent kidney stones: A systematic review and meta-analysis.遗传多态性作为复发性肾结石的预后因素：系统评价和荟萃分析。
PLoS One. 2021 May 6;16(5):e0251235. doi: 10.1371/journal.pone.0251235. eCollection 2021.

本文引用的文献

1
Combined vitamin D and calcium supplementation in vitamin D inadequate patients with urolithiasis: Impact on hypercalciuria and de novo stone formation.维生素D不足的尿路结石患者联合补充维生素D和钙：对高钙尿症和新发结石形成的影响。
Can Urol Assoc J. 2015 Nov-Dec;9(11-12):403-8. doi: 10.5489/cuaj.3332. Epub 2015 Dec 14.
2
Nomogram to predict uric acid kidney stones based on patient's age, BMI and 24-hour urine profiles: A multicentre validation.基于患者年龄、体重指数和24小时尿液指标预测尿酸肾结石的列线图：一项多中心验证研究
Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E178-82. doi: 10.5489/cuaj.2682.
3
Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism.血钙正常的甲状旁腺功能亢进与高钙血症性甲状旁腺功能亢进的并发症相似。
J Bone Miner Metab. 2016 May;34(3):331-5. doi: 10.1007/s00774-015-0673-3. Epub 2015 Jun 9.
4
The nutrition consult for recurrent stone formers.复发性结石形成者的营养咨询。
Curr Urol Rep. 2015 Jul;16(7):47. doi: 10.1007/s11934-015-0518-6.
5
Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis.高液体摄入量预防新发和复发性肾结石的治疗效果、依从性及安全性：一项系统评价和荟萃分析
J Nephrol. 2016 Apr;29(2):211-219. doi: 10.1007/s40620-015-0210-4. Epub 2015 May 29.
6
100% uric acid stone formers: what makes them different?100% 尿酸结石形成者：有何不同？
Urology. 2015 Feb;85(2):296-8. doi: 10.1016/j.urology.2014.10.029. Epub 2014 Oct 30.
7
Association of urinary calcium excretion with serum calcium and vitamin D levels.尿钙排泄与血清钙及维生素D水平的关联。
Clin J Am Soc Nephrol. 2015 Mar 6;10(3):452-62. doi: 10.2215/CJN.12511213. Epub 2014 Dec 17.
8
Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.代谢评估和预防尿路结石患者复发：EAU 指南。
Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20.
9
Caffeine intake and the risk of kidney stones.咖啡因摄入与肾结石风险
Am J Clin Nutr. 2014 Dec;100(6):1596-603. doi: 10.3945/ajcn.114.089987. Epub 2014 Oct 1.
10
Bone mineral density status in urolithiasis patients with vitamin D inadequacy followed at a tertiary stone centre.在一家三级结石中心随访的维生素D缺乏的尿石症患者的骨矿物质密度状况
Can Urol Assoc J. 2014 Sep;8(9-10):323-8. doi: 10.5489/cuaj.2055.